Sara Gutierrez joins SHL as the Chief Science Officer
The science leader comes with a rich experience in the employment testing industry
The science leader comes with a rich experience in the employment testing industry
Dupixent peak sales ambition raised to more than €13 billion
50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age
More than 120 speakers and 5,000 delegates are expected to attend
#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India
The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Subscribe To Our Newsletter & Stay Updated